FGFR2 and gastric cancer: It is now confirmed that only high CNVs actually translate into high protein expression, which decreases the prevalence of FGFR-positive patients, usually to a low percentage of the overall population (e.g., 4% for FGFR2-amplified gastric cancer [130,131]).